MEDISPA.PRO
Ministry of Health code: A17.30.009 Axis M5 · Cardiometabolic health and microcirculation CEBM: Level A (Device-based lymphatic drainage and phlebology)

Hardware intermittent pneumatic compression (pressotherapy / lymphatic drainage)

Intermittent Pneumatic Compression (Pressotherapy)

Industry clinical and economic procedure passport. Full biological mechanism (MoA), patient preparation protocol, first-choice equipment fleet, integration into the resort's master treatment rooms and market price benchmarks.

Session duration
45 min
Turnover: ~60 min
Recommended course
10 sessions
every other day or daily (10–12 sessions)
Throughput capacity
8 pts
per 8-hour shift
Median rate
2 725 ₽
2 150 ₽ – 3 400 ₽
Course cost
27 250 ₽
at market median
Publication volume
Level A
11 publ. in PubMed

Clinical profile

Device-based intermittent pneumatic compression of the limbs with cuffs inflated sequentially. Medical indications with evidence are thrombosis prevention (together with anticoagulants), lymphoedema, post-thrombotic syndrome and severe limb ischaemia in inoperable patients; for post-exercise recovery the data do not yet show an effect.

Every statement links to a publication in the list below. This is a snapshot of published research, not a final assessment of the method: international practice and integrated protocols often run ahead of official publications. Draft based on published research; requires review by a physician. Revision: 2026-10-17.

Mechanism of action

  • Improved lymphatic outflow and reduced interstitial fluid accumulation are expected. [6]

Where studies show an effect

  • Prevention of venous thromboembolism: combined with pharmacological prophylaxis it reduces the incidence of DVT (high certainty) and PE compared with drugs alone. [1, 2]
  • Limb lymphoedema: reduced volume of the swollen limb, including at home together with compression garments. [4, 5]
  • Prevention of lymphoedema after breast cancer treatment when started early (pressure up to 40 mmHg, for more than two weeks). [6]
  • Post-thrombotic syndrome: low-certainty evidence in favour of pneumatic compression for symptom severity. [3]
  • Severe leg ischaemia in patients for whom revascularisation is not available: possible benefit for limb salvage, healing and pain. [8, 9]
  • Haemodialysis: fewer episodes of intradialytic hypotension. [10]

Open questions and study limitations

  • After exercise, pneumatic compression does not reduce muscle soreness compared with control. [11]
  • In established lymphoedema after breast cancer, a 2014 meta-analysis found no effect from adding pneumatic compression to usual care. [7]
  • In limb ischaemia and haemodialysis, studies have a high risk of bias; high-quality trials are needed. [8, 10]

Safety

  • Pain during compression, chafing and contact rash from the cuff are possible. [8]

Protocol in studies

  • In lymphoedema, significant results were obtained with 45–60-minute sessions at 30–60 mmHg in sequential mode. [5]
Contraindications. Contraindications (including acute thrombosis and decompensated heart failure) are determined by the physician according to the device instructions; they are not given in study abstracts.

Equipment fleet and fit-out

Certified first-choice medical equipment and compatible device systems

Equipment registry
Base configuration (Hero Device)
BTL-6000 Lymphastim 12 Topline pressotherapy device

Device platform with proven validation of the biological response. Includes built-in biofeedback sensor systems, patient protection protocols and precision dosing of exposure.

Certification: Russian Ministry of Health registration certificate / CE Medical Device Directive Class IIa/IIb.
Compatible platforms in the MEDISPA.PRO registry
Limpha Press physiotherapy device for pressotherapy and lymphatic drainage, with accessories
Medical device, Roszdravnadzor registration certificate / CE
In the registry →

Architectural integration and treatment rooms

Resort rooms housing the treatment station (with SanPiN norms and MEP loads)

All treatment rooms →

Unit economics and resort price benchmarks

Market analysis based on a sample of premium sanatoriums, wellness hotels and preventive medicine clinics

Market price corridor
25th percentile (P25) 2 150 ₽
Market median 2 725 ₽
75th percentile (P75) 3 400 ₽

Median of prices in industry facilities' price lists, 2026

Basis of the price benchmark

Prices for this procedure appear in the price lists of 9 industry facilities; the median and interquartile range across facilities are shown (each facility counts once).

Evidence base

For thrombosis prevention, Cochrane reviews of high certainty; for lymphoedema and limb ischaemia, low-level reviews; for post-exercise recovery, no data on benefit yet.

Publication level A · Plenty of data
  1. 1.
    Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism.
    Cochrane Database Syst Rev, 2022 · Cochrane systematic review · PMID 35089599
    Pneumatic compression with anticoagulants reduces DVT (high certainty) and PE compared with drugs alone.
  2. 2.
    Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism.
    Cochrane Database Syst Rev, 2016 · Cochrane systematic review · PMID 27600864
    Combining pneumatic compression with drug prophylaxis reduces DVT and PE compared with either method alone.
  3. 3.
    Compression therapy for treating post-thrombotic syndrome.
    Cochrane Database Syst Rev, 2019 · Cochrane systematic review · PMID 31531971
    Post-thrombotic syndrome: low-certainty evidence in favour of pneumatic compression for severity.
  4. 4.
    Intermittent pneumatic compression therapy: a systematic review.
    Lymphology, 2012 · Systematic review · PMID 22768469
    Pneumatic compression reduces the volume of a lymphoedematous limb; there are no standard parameters.
  5. 5.
    Intermittent Pneumatic Compression Dosage for Adults and Children with Lymphedema: A Systematic Review.
    Lymphat Res Biol, 2019 · Systematic review · PMID 30339493
    Lymphoedema: effect at 45–60 minutes and 30–60 mmHg; low-level evidence.
  6. 6.
    Intermittent pneumatic compression devices for the prevention and treatment of breast cancer-related lymphedema-a systematic review and meta-analysis.
    Support Care Cancer, 2025 · Systematic review and meta-analysis · PMID 41272206
    Pneumatic compression prevents lymphoedema after breast cancer; in chronic lymphoedema the effect is limited.
  7. 7.
    Intermittent pneumatic compression pump for breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trials.
    Oncol Res Treat, 2014 · Systematic review and meta-analysis of RCTs · PMID 24732640
    Adding pneumatic compression to standard treatment of lymphoedema after breast cancer showed no effect in this analysis.
  8. 8.
    A systematic review of intermittent pneumatic compression for critical limb ischaemia.
    Vasc Med, 2015 · Systematic review · PMID 25270409
    Critical limb ischaemia: possible benefit, high-quality trials are needed; complications include pain, chafing and rash.
  9. 9.
    Intermittent pneumatic compression for the treatment of lower extremity arterial disease: a systematic review.
    Vasc Med, 2002 · Systematic review · PMID 12402994
    Promising in severe peripheral arterial disease in inoperable patients.
  10. 10.
    Intermittent pneumatic compression in patients with ESRD. A systematic review.
    Hemodial Int, 2019 · Systematic review · PMID 31283096
    On haemodialysis, less intradialytic hypotension; high risk of bias.
  11. 11.
    Effects of photobiomodulation, intermittent pneumatic compression and neuromuscular electrical stimulation on muscle recovery: Systematic review with meta-analysis.
    J Bodyw Mov Ther, 2025 · Systematic review and meta-analysis · PMID 40954632
    After exercise, pneumatic compression does not reduce muscle soreness.

Publications were found in PubMed; titles and journals are given verbatim, conclusions are a brief summary of the abstracts under the conditions of the specific studies. The level shows the volume of published data, not the value of the method: A — Plenty of data: consistent systematic reviews and meta-analyses of RCTs; B — Some data: reviews or several RCTs, results are heterogeneous; C — Little data: single RCTs or controlled studies; D — Scarce data: mainly reviews, observational and experimental studies. The passport is updated as new work is published and with regard to international practice.